Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2022-01-17 Major Shareholding Noti…
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Samil Pharmaceutical. It details specific changes in share ownership by individuals classified as major shareholders or related parties, including transaction dates, share counts, and percentage changes. This falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels.
2022-01-17 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Contract' (신탁계약등에의한취득상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the company's (Samil Pharmaceutical) share buyback activity conducted through a trust agreement with NH Investment & Securities. This type of filing specifically reports the company's transactions in its own shares, which falls under the 'Transaction in Own Shares' category.
2022-01-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in shareholding percentage by Susung Asset Management in Samil Pharmaceutical. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the shareholding changes of a specific executive (Heo Seung-beom) of Samil Pharmaceutical. This type of filing is a standard regulatory disclosure for insider trading or changes in ownership by directors/major shareholders, which corresponds to the 'Director's Dealing' category.
2021-12-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership, changes in holdings, and special relationships of major shareholders (Heo Seung-beom and others) in Samil Pharmaceutical. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-12-28 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Samil Pharmaceutical. It details specific share transactions by a director/major shareholder (Heo Seung-beom) and provides a summary of the total shareholding status of major shareholders. This type of filing is a standard regulatory disclosure for insider share transactions and changes in major shareholding positions, which falls under the 'Director's Dealing' category.
2021-12-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.